Why Clinical Trials for Diffuse Large B-Cell Lymphoma Are So Important

Article Fact Checked

Medically Reviewed

/ Updated December 29th, 2020

Why Clinical Trials for Diffuse Large B-Cell Lymphoma Are So Important

×
NOW
PLAYING
"A Second Opportunity at Life"-- Maribel Ramos Is Thriving 5 Years After Experimental Immunotherapy for Triple-Negative Breast Cancer
NOW
PLAYING
Black Americans Don't Get Screened or Treated for Lung Cancer at the Same Rates as White Americans: Here's Why, and What We Can Do About It
NOW
PLAYING
The First Targeted Therapy For Lung Cancer Patients With The KRAS Gene Mutation--Extraordinary Results With Sotorasib
NOW
PLAYING
New COVID-19 Stimulus Bill Opens Cancer Clinical Trials to Millions Who Were Previously Excluded
NOW
PLAYING
A Record Decline in Cancer Death Rates; The Immunotherapy Revolution And How It's Changing Cancer Treatment
NOW
PLAYING
How a Clinical Trial Might Improve Your Outlook

Treatment : Understanding the Options for Diffuse Large B-Cell Lymphoma

SEE MORE   

  • The treatment you get for non-Hodgkin lymphoma will depend on the type of lymphoma, the stage and the how fast it’s growing
  • Diffuse large B-cell lymphoma is the most common type diagnosed in the United States and worldwide
  • People with aggressive non-Hodgkin lymphoma can expect to get a chemotherapy combination called R-CHOP

Treatment : Understanding the Options for Diffuse Large B-Cell Lymphoma

  • The treatment you get for non-Hodgkin lymphoma will depend on the type of lymphoma, the stage and the how fast it’s growing
  • Diffuse large B-cell lymphoma is the most common type diagnosed in the United States and worldwide
  • People with aggressive non-Hodgkin lymphoma can expect to get a chemotherapy combination called R-CHOP

Treatment : Chemotherapy

SEE MORE   

Treatment : Treating Non-Hodgkin Lymphoma in Children

SEE MORE   

Treatment : Treating Non-Hodgkin Lymphoma in Children

  • Children with non-Hodgkin lymphoma are typically given more aggressive chemotherapy because their bodies are generally able to tolerate it better
  • Long-term survival in children with B-cell non-Hodgkin lymphoma is over 90%

Treatment : Mantle Cell Lymphoma

SEE MORE   

  • Mantle cell lymphoma is a type of non-Hodgkin lymphoma
  • The disease can be either slow-growing (indolent) or fast-growing (aggressive)
  • Aggressive mantle cell lymphoma may be treated with a combination of a monoclonal antibody (rituximab) and chemotherapy

Treatment : Mantle Cell Lymphoma

  • Mantle cell lymphoma is a type of non-Hodgkin lymphoma
  • The disease can be either slow-growing (indolent) or fast-growing (aggressive)
  • Aggressive mantle cell lymphoma may be treated with a combination of a monoclonal antibody (rituximab) and chemotherapy
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.